{"name":"Talaris Therapeutics Inc.","slug":"talaris-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":66985000,"netIncome":-73210000,"cash":30506000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTFBScXRtQ0tnTHAtQ1RNeTQwUm9HcmNXWXVJUzg0NGo4b2dUVnVYSS01ekpBUlpXa1J0bDlpWlhham5ubzhYZXh4dW5yanlVR19ZSnc?oc=5","date":"2025-06-06","type":"trial","source":"Endpoints News","summary":"IPO Tracker (2021) - Endpoints News","headline":"IPO Tracker (2021)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNWU5WNWVCRG1DRjFYWGZRZWFYaXppZFVBZnJtTEVnb1M2RG9WM29OV0laR2Rac2FjRmItYVBwWG5MczFKam84RGNZZXJlbVlEZnNJVThjd1M5NFB3amdBQkMyZGtzbUdJUlYxVmc3UnJobTV1R1d2dnFKNm9mSk1lRTROb1dNY1dPdnRmWW8wLWtYTE9u?oc=5","date":"2024-01-02","type":"pipeline","source":"bizjournals.com","summary":"The definitive Boston biotech layoff tracker for 2023 - bizjournals.com","headline":"The definitive Boston biotech layoff tracker for 2023","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE82am1GWUp6anoyR0h0MTM0eWFlNE8xYnFZX0NydTlVNDd3WTZ4c1dNRmROdktvSGU2dVZjYjVQbHVQVkw1R1pXdWxaZkk1c3kyVnJVS1RRcnRLYnJWcHppaVNzSDAyemtIV2FjM05pdU5mbUZzVHVVQ0xnSVM?oc=5","date":"2023-12-20","type":"deal","source":"BioCentury","summary":"2023’s biotech reverse mergers - BioCentury","headline":"2023’s biotech reverse mergers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxNby1hbHVTa056TlZsbl9qNDJvUFpIem9HTUpBbGJKVXRYWGl0RGhQYkplTktDc3A4V21lQWdLU2VickNjY0J6dTJ2d2phV0JIcTdISlJ6Wld1NDFNMzFIQXlzOHJKZHhuZENqLTdqdllLSVRiSXV1MUg4LUQxd1NsRTZFNXROR0U2bjZIUUV1QWhxSmRmaHpUaThQRmowN1dWSzl1clVMZllGbGZ6RF9SM1c5UFM4RUNQMzZQbk9WcGt1aTNKOFFqTDJqVUNHU3MtYUotUl9DWU5EcG5NeWdmd29B?oc=5","date":"2023-12-12","type":"pipeline","source":"WDRB","summary":"Biotech company hopes to make Louisville a hub for cell therapy - WDRB","headline":"Biotech company hopes to make Louisville a hub for cell therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQdVM1QUI4ZU5WT2YtaUI3cDV3ek9lNHBvSVdrZm1xVDNKZV9uaER2V0d0WkdycEhmT1lQdDBkZTJDZlh4eEtrN2JPa1Z6b1VlRXRGNWliWHhBU1pCRU43WFBOUERpRmU5SXBiQVpVQ014TVZYdzlPSHlqeDM4UjdhOHVzcTh4WnVmanY0?oc=5","date":"2023-06-23","type":"pipeline","source":"Pharmaceutical Technology","summary":"Talaris Therapeutics to merge with Tourmaline Bio - Pharmaceutical Technology","headline":"Talaris Therapeutics to merge with Tourmaline Bio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNZVFpUmRmOWhfVFVGbmZRYVB6Y3RLLVFZc3lGZG1jTE1KSUZSMW9nRFRoM09XSnJYMDRnNUsxOHo1bGlyeWZFZ0M5NFFQNlRQODM3WGg1WnJzOEhBLU1DUTZ4UFBjblE0RWVoUm44Y29VSjlVR2QzblZIV3dvVEFhVVVGZktQc25fY1ZvQw?oc=5","date":"2023-06-22","type":"deal","source":"BioPharma Dive","summary":"Talaris, Tourmaline to combine in biotech’s latest reverse merger - BioPharma Dive","headline":"Talaris, Tourmaline to combine in biotech’s latest reverse merger","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxOc085V0NSUjg0VHVIRmoxdWtxcnc4Mkc1RkhtLTJaWUpRclM5ODNUVlJpaDBuOXQ3dGQ1cGFYTFN0enYxZ0dLTDRrYkdFd3llMGpYU29ZVC1GSlE2bG00VVBsWkNVekJCYk5NVW5HVkZpb0FCWjRuTnY3MVdLNE1lNUxLZ2RtNWJBeHZoc2NkbGtpek5mUXd1ZDJNTW5NbWdIQTUwbDZsd3lBQTJmdDRQZXl5UHBnQk1pLTFEZ2pjRmJFa2VvbTlRWmJVd2o4ekJtSWs4?oc=5","date":"2023-06-22","type":"deal","source":"GlobeNewswire","summary":"Talaris Therapeutics and Tourmaline Bio Announce Merger Agreement - GlobeNewswire","headline":"Talaris Therapeutics and Tourmaline Bio Announce Merger Agreement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxQdHNFXzVSMHVURTRFdHMwUm9zOVhpX0NxU3I0ZXRwLUtwSi05NVF1Z3NXRTQ5TjItTWJJNzlOYTU1MjRFY3l4RlVmX29TX2pYMXdCam42T28zX1ZvQzdQZ2l2dHFEUDJKbS0wVDkxSjRPNDZ2SlNpUkw3LVNaNUVOQXBoUlQyWjVsOV93anZweW5IMlMyZkJraGNUUmZVSE14TEpWY2FZekRmWXBWWi1nTGtNTngydERWN1NkcHNpUUFWZXV2Ymc?oc=5","date":"2023-06-22","type":"trial","source":"Fierce Biotech","summary":"Tourmaline heads to Nasdaq, inking Talaris reverse merger to fund midphase trials of Pfizer castoff - Fierce Biotech","headline":"Tourmaline heads to Nasdaq, inking Talaris reverse merger to fund midphase trials of Pfizer castoff","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNZm1wN2h2aXF3OTJ0bEhNN0RiZVN6VUpPSzE4RXJFMFlISW1aSkRqTFlrbjFyWDdTT0JDaElEVUdVQXNkcHFveGVLT1oyV2tLcVhSc01iU2ljM0ZQRTFkNkNFaHJyWlp6OXFvRmRmY2x5R1YxOXpmUTQ3S2pUd1hzYnpJNG9nUlhwbTB0dzNSa0JtMnZCd2RiOUJSajlPUzdGY2RDYTA2SGpVUDkzVkp6ajhpS18?oc=5","date":"2023-04-17","type":"pipeline","source":"Fierce Biotech","summary":"Talaris lays off 95% of workforce, C-suite as kidney transplant company fails to find a savior - Fierce Biotech","headline":"Talaris lays off 95% of workforce, C-suite as kidney transplant company fails to find a savior","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPODd3RzRFMlhnV2x1VWNWZldEUUtwb01uN3dqWWJSa0NBMW1lXzh2MDMxb2JVbFBUMUhRZGhZckNvUFhEMldmdkhoeXl3SXJna0t3eWQxTDQxXzdZUmRNdTBac3RkMnJrQnBBM3dsX010dl9wWWJnSU55cXBTT3RLcG41WmEzbFl5dkJzUFFVbjZLeGR2Mk1xRmpjaw?oc=5","date":"2023-02-16","type":"pipeline","source":"BioPharma Dive","summary":"Talaris restructures, ending effort to develop a cell therapy for kidney transplants - BioPharma Dive","headline":"Talaris restructures, ending effort to develop a cell therapy for kidney transplants","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOWGRTTHZuZVdMWl95SkMxU0xwWjh0Z3N1eFpJbHFoZTl6QWNuR3g5SWFlVVBlTHJwT1ViQUY5TGI1cHpSSFAtS1N6TmxFallyT2l4eDhtcUVhMDFZVTB5Q2R6N09Xd0xYMTJJckY3cUJjM2VlaUhrYzBOMUoxZlAxWWIzamlXZ1duWXg0SzNvQVhKTVdrc2pDWkFUcw?oc=5","date":"2021-11-04","type":"pipeline","source":"pharmaphorum","summary":"Talaris therapy ends need for immune drugs in transplant patients - pharmaphorum","headline":"Talaris therapy ends need for immune drugs in transplant patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE84SlotTWpVR0J3NjRBNUxnVlgyMUpWMFowT21XVkZkSVpPYjVOMVVvbHdRTThkUVBMamV3UlZGVDF5a3pIQVBXeUhvSGlkNTk1aExSRDNwcEFlU1dpUXBRYkZPV3J0QQ?oc=5","date":"2021-05-05","type":"pipeline","source":"Investing.com","summary":"Tourmaline Bio Inc Stock Price Today | NASDAQ: TRML Live - Investing.com","headline":"Tourmaline Bio Inc Stock Price Today | NASDAQ: TRML Live","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":66985000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-73210000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":30506000,"cashHistory":[],"totalAssets":309001000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}